Literature DB >> 28439801

Extensive Retropharyngeal and Spinal Plexiform Neurofibromas in a Neonate with Type 1-Neurofibromatosis.

Meghmala Sadhukhan1, Brendon Conry2, Bim Bhaduri3.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28439801     DOI: 10.1007/s12098-017-2349-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  5 in total

1.  Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.

Authors:  Edwin Jousma; Tilat A Rizvi; Jianqiang Wu; David Janhofer; Eva Dombi; Richard S Dunn; Mi-Ok Kim; Andrea R Masters; David R Jones; Timothy P Cripe; Nancy Ratner
Journal:  Pediatr Blood Cancer       Date:  2015-04-22       Impact factor: 3.167

Review 2.  National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987.

Authors: 
Journal:  Neurofibromatosis       Date:  1988

Review 3.  Peripheral nerve tumors: management strategies and molecular insights.

Authors:  Asis Kumar Bhattacharyya; Richard Perrin; Abhijit Guha
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

4.  Massive plexiform neurofibromas in childhood: natural history and management issues.

Authors:  Demitre Serletis; Patricia Parkin; Eric Bouffet; Manohar Shroff; James M Drake; James T Rutka
Journal:  J Neurosurg       Date:  2007-05       Impact factor: 5.115

5.  NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.

Authors:  Alessandro De Luca; Irene Bottillo; Anna Sarkozy; Claudio Carta; Cinzia Neri; Emanuele Bellacchio; Annalisa Schirinzi; Emanuela Conti; Giuseppe Zampino; Agatino Battaglia; Silvia Majore; Maria M Rinaldi; Massimo Carella; Bruno Marino; Antonio Pizzuti; Maria Cristina Digilio; Marco Tartaglia; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2005-10-26       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.